Search research articles
Contact Us
Filters
Showing results (91-100 of 134) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Celeste Lebbe, Jürgen C Becker, Jean-Jacques Grob, et al.
International Journal of Cancer
|
April 29, 2026
Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond
Yago Garitaonaindia, Søren Kjær Petersen, Louise M Guldbrandt, et al.
Head & Neck
|
September 4, 2003
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA
Cai Grau, Lars Vendelbo Johansen, Hanne Sand Hansen, et al.
Journal of the National Cancer Institute
|
June 17, 2026
Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma
Yago Garitaonaindia, Adam A Luczak, Christina H Ruhlmann, et al.
Cancers
|
October 19, 2019
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Kalijn Fredrike Bol, Eva Ellebaek, Lise Hoejberg, et al.
The New England Journal of Medicine
|
July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2025
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022)
Sidsel Pedersen, Emma Lund Johansen, Karen Louise Højholt, et al.
Cancers
|
November 13, 2021
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
Morten Fink, Anders Schwartz Vittrup, Lars Bastholt, et al.
Endocrine-Related Cancer
|
June 3, 2024
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
Marcia S Brose, Jaume Capdevila, Rossella Elisei, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 134) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Celeste Lebbe, Jürgen C Becker, Jean-Jacques Grob, et al.
International Journal of Cancer
|
April 29, 2026
Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond
Yago Garitaonaindia, Søren Kjær Petersen, Louise M Guldbrandt, et al.
Head & Neck
|
September 4, 2003
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA
Cai Grau, Lars Vendelbo Johansen, Hanne Sand Hansen, et al.
Journal of the National Cancer Institute
|
June 17, 2026
Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma
Yago Garitaonaindia, Adam A Luczak, Christina H Ruhlmann, et al.
Cancers
|
October 19, 2019
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Kalijn Fredrike Bol, Eva Ellebaek, Lise Hoejberg, et al.
The New England Journal of Medicine
|
July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2025
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022)
Sidsel Pedersen, Emma Lund Johansen, Karen Louise Højholt, et al.
Cancers
|
November 13, 2021
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
Morten Fink, Anders Schwartz Vittrup, Lars Bastholt, et al.
Endocrine-Related Cancer
|
June 3, 2024
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
Marcia S Brose, Jaume Capdevila, Rossella Elisei, et al.
Page
of 14